Physician profile
Guita Tabassi
NPI 1982677472
$6,955.17
in general payments reported to CMS, 2019-2025
38 companies · $735 in 2025
The $735 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $594 · 2021: $788 · 2022: $3,053 · 2023: $969 · 2024: $512 · 2025: $735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,031 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,031.39 |
| Education | $184.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,493.13 | 2021-2022 | |
| Hologic Sales and Service, LLC | $823.53 | 2019-2025 | Novasure, Fluent Fluid Management System, Acessa Provu System |
| Abbvie INC. | $557.27 | 2020-2024 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $524.38 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $402.92 | 2021-2025 | |
| Minerva Surgical, INC | $348.26 | 2019-2024 | |
| Exeltis, USA INC. | $187.32 | 2019-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $161.53 | 2021-2025 | |
| Organon LLC | $158.18 | 2021-2025 | Nexplanon, Jada System |
| Shield Therapeutics INC | $117.02 | 2022-2024 | Accrufer |
| Therapeuticsmd, INC. | $115.03 | 2019-2022 | |
| Intuitive Surgical, INC. | $114.60 | 2020 | |
| Daiichi Sankyo INC. | $93.87 | 2019-2022 | |
| Avion Pharmaceuticals | $72.26 | 2019-2023 | Balcoltra |
| Medicem INC. | $69.42 | 2021-2023 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $63.00 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $54.72 | 2019-2021 | |
| Allergan, INC. | $51.41 | 2019-2020 | |
| Coopersurgical, INC. | $50.64 | 2021-2024 | Paragard T 380a |
| Pfizer INC. | $48.83 | 2022-2025 | |
| Aspira Women'S Health INC | $40.98 | 2020-2024 | Ova1 |
| Sage Therapeutics, LLC | $37.45 | 2025 | Zurzuvae |
| Optumhealth Care Solutions, LLC | $34.01 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Myovant Sciences INC. | $33.86 | 2021 | |
| Agile Therapeutics, INC. | $33.40 | 2022-2023 | Twirla |
| Sumitomo Pharma America, INC. | $30.71 | 2024-2025 | Myfembree |
| Covidien Lp | $26.83 | 2019-2020 | |
| Axonics, INC. | $24.26 | 2023 | Bulkamid, Axonics |
| Mycovia Pharmaceuticals, INC. | $23.23 | 2023 | Vivjoa |
| Lupin INC. | $23.17 | 2019 | |
| Coloplast Corp | $22.84 | 2024 | |
| Gynesonics, INC. | $20.88 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Roche Diagnostics Corporation | $19.36 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $16.72 | 2023 | Bd Onclarity |
| Supernus Pharmaceuticals, INC. | $16.46 | 2025 | Qelbree |
| Mylan Pharmaceuticals INC. | $16.19 | 2021 | |
| Amag Pharmaceuticals, INC. | $14.13 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $13.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guita Tabassi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.